+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Glaucoma Market and Competitive Landscape - 2020

  • ID: 5023441
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Glaucoma Market and Competitive Landscape - 2020, provides comprehensive insights into the Glaucoma pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Glaucoma market size and drug sales. It also provides insights into Glaucoma epidemiology and late stage pipeline.

This research covers the following: Glaucoma treatment options, Glaucoma late stage clinical trials pipeline, Glaucoma prevalence by countries, Glaucoma market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Glaucoma pipeline: Find out drugs in clinical trials for the treatment of Glaucoma by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Glaucoma epidemiology: Find out the number of patients diagnosed (prevalence) with Glaucoma by countries
  • Glaucoma drugs: Identify key drugs marketed and prescribed for Glaucoma in the US, including trade name, molecule name, and company
  • Glaucoma drugs sales: Find out the sales value for Glaucoma drugs by countries
  • Glaucoma market valuations: Find out the market size for Glaucoma drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Glaucoma drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Glaucoma drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Glaucoma market
  • Develop in-depth knowledge of competition and markets
  • Analyze Glaucoma drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Glaucoma market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Glaucoma Treatment Options

2. Glaucoma Pipeline Insights
2.1. Glaucoma Phase 3 Clinical Trials
2.2. Glaucoma Phase 2 Clinical Trials
2.3. Glaucoma Phase 1 Clinical Trials

3. Glaucoma Epidemiology Analysis by Countries

4. Germany Glaucoma Market Insights
4.1. Marketed Drugs for Glaucoma in Germany
4.2. Germany Glaucoma Market Size & Forecast
4.3. Germany Glaucoma Drugs Sales Forecast
4.4. Germany Glaucoma Market Share Analysis

5. France Glaucoma Market Insights
5.1. Marketed Drugs for Glaucoma in France
5.2. France Glaucoma Market Size & Forecast
5.3. France Glaucoma Product Sales Forecast
5.4. France Glaucoma Market Share Analysis

6. Italy Glaucoma Market Insights
6.1. Marketed Drugs for Glaucoma in Italy
6.2. Italy Glaucoma Market Size & Forecast
6.3. Italy Glaucoma Product Sales Forecast
6.4. Italy Glaucoma Market Share Analysis

7. Spain Glaucoma Market Insights
7.1. Marketed Drugs for Glaucoma in Spain
7.2. Spain Glaucoma Market Size & Forecast
7.3. Spain Glaucoma Product Sales Forecast
7.4. Spain Glaucoma Market Share Analysis

8. UK Glaucoma Market Insights
8.1. Marketed Drugs for Glaucoma in UK
8.2. UK Glaucoma Market Size & Forecast
8.3. UK Glaucoma Product Sales Forecast
8.4. UK Glaucoma Market Share Analysis

9. Europe Glaucoma Market Insights
9.1. Europe Glaucoma Market Size & Forecast
9.2. Europe Glaucoma Product Sales Forecast
9.3. Europe Glaucoma Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Glaucoma Phase 3 Clinical Trials, Global, 2020
Table 2: Glaucoma Phase 2 Clinical Trials, Global, 2020
Table 3: Glaucoma Phase 1 Clinical Trials, Global, 2020
Table 4: Glaucoma Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Glaucoma in Germany, 2019
Table 6: Germany Glaucoma Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Glaucoma Product Sales ($mn), 2016 - 2024
Table 8: Germany Glaucoma Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Glaucoma in France, 2019
Table 10: France Glaucoma Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Glaucoma Product Sales ($mn), 2016 - 2024
Table 12: France Glaucoma Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Glaucoma in Italy, 2019
Table 14: Italy Glaucoma Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Glaucoma Product Sales ($mn), 2016 - 2024
Table 16: Italy Glaucoma Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Glaucoma in Spain, 2019
Table 18: Spain Glaucoma Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Glaucoma Product Sales ($mn), 2016 - 2024
Table 20: Spain Glaucoma Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Glaucoma in UK, 2019
Table 22: UK Glaucoma Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Glaucoma Product Sales ($mn), 2016 - 2024
Table 24: UK Glaucoma Market Events and Trends, 2016 - 2024
Table 25: Europe Glaucoma Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Glaucoma Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Glaucoma Pipeline by Phase (%), Global, 2020
Figure 2: Glaucoma Prevalence by Countries, 2016 - 2024
Figure 3: Germany Glaucoma Market Size ($mn), 2016 - 2024
Figure 4: Germany Glaucoma Product Sales ($mn), 2016 - 2024
Figure 5: Germany Glaucoma Market Share by Drugs (%), 2019
Figure 6: Germany Glaucoma Market - Future Market Share (%), 2024
Figure 7: France Glaucoma Market Size ($mn), 2016 - 2024
Figure 8: France Glaucoma Product Sales ($mn), 2016 - 2024
Figure 9: France Glaucoma Market Share by Drugs (%), 2019
Figure 10: France Glaucoma Market - Future Market Share (%), 2024
Figure 11: Italy Glaucoma Market Size ($mn), 2016 - 2024
Figure 12: Italy Glaucoma Product Sales ($mn), 2016 - 2024
Figure 13: Italy Glaucoma Market Share by Drugs (%), 2019
Figure 14: Italy Glaucoma Market - Future Market Share (%), 2024
Figure 15: Spain Glaucoma Market Size ($mn), 2016 - 2024
Figure 16: Spain Glaucoma Product Sales ($mn), 2016 - 2024
Figure 17: Spain Glaucoma Market Share by Drugs (%), 2019
Figure 18: Spain Glaucoma Market - Future Market Share (%), 2024
Figure 19: UK Glaucoma Market Size ($mn), 2016 - 2024
Figure 20: UK Glaucoma Product Sales ($mn), 2016 - 2024
Figure 21: UK Glaucoma Market Share by Drugs (%), 2019
Figure 22: UK Glaucoma Market - Future Market Share (%), 2024
Figure 23: Europe Glaucoma Market Size ($mn), 2016 - 2024
Figure 24: Europe Glaucoma Product Sales ($mn), 2016 - 2024
Figure 25: Europe Glaucoma Market Share by Drugs (%), 2019
Figure 26: Europe Glaucoma Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll